EUROAPI Hungary Ltd.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Lessors of Real Property, Not Elsewhere Classified, Land Subdividers and Developers, Except Cemeteries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about EUROAPI Hungary Ltd.
Live alerts from global media, monitored by Business Radar
2025-03-07 (proteste.pt)
ENI, EuroPi, Vallourec
Eni in partnership with Petronas da Malaysia. Euroapi losses accumulate. Vallourec pay dividends again.
Read more
2024-09-18 (businesswire.com)
Aizon Launches New AI-powered eBR Light Solution to Enhance Manufacturing Productivity in Collaboration with Euroapi | Business Wire
Aizon, an Artificial Intelligence (AI) SaaS provider dedicated to transforming pharmaceutical manufacturing operations, is launching a new product cal
Read more
2024-06-26 (globenewswire.com)
EUROAPI is moving ahead with its FOCUS-27 plan, setting the foundations for future profitable growth1
Press Release Agreement with Sanofi on a 200 M€ investment through a Perpetual Subordinated Hybrid Bond, upon the completion of the...
Read more
2023-03-08 (businesswire.com)
EUROAPI: Full-Year 2022 Results | Business Wire
Regulatory News: EUROAPI (Paris:EAPI): 2022 highlights1 €976.6 million Net Sales, up 8.5%, driven by solid performance in both CDMO (+18.3%), and API
Read more
2022-06-01 (contractpharma.com)
EUROAPI Expands Collaboration with Sanofi |
Will support Sanofi's mRNA vaccine platform with the development of lipid nanoparticles.
Read more